Hikma Pharmaceuticals (HKMPY) Short Interest Ratio & Short Volume → Crypto Market Preps For Trillions Worth of Inflows! (From Crypto 101 Media) (Ad) Free HKMPY Stock Alerts $47.48 -1.22 (-2.51%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesShort InterestStock AnalysisChartDividendHeadlinesShort Interest Hikma Pharmaceuticals Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$4,864.00Short Interest Ratio / Days to Cover0.2Last Record DateMarch 15, 2024Today's Trading Volume225 sharesAverage Trading Volume436 sharesToday's Volume Vs. Average52% Short Selling Hikma Pharmaceuticals ? Sign up to receive the latest short interest report for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHKMPY Short Interest Over TimeHKMPY Days to Cover Over TimeHKMPY Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Hikma Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2024100 shares $4,864.00 No ChangeN/A0.2 $48.64 2/29/2024100 shares $5,028.55 -50.0%N/A0.2 $50.29 2/15/2024200 shares $9,980.00 No ChangeN/A0.5 $49.90 1/15/2024300 shares $14,925.00 +200.0%N/A0.5 $49.75 12/31/2023100 shares $4,541.10 No ChangeN/A0.1 $45.41 11/15/2023100 shares $4,247.00 No ChangeN/A0.2 $42.47 Get the Latest News and Ratings for HKMPY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/31/2023100 shares $4,744.20 No ChangeN/A0.2 $47.44 10/15/2023100 shares $5,232.00 -66.7%N/A0.3 $52.32 9/30/2023300 shares $15,696.00 -40.0%N/A0.5 $52.32 9/15/2023500 shares $26,350.00 -58.3%N/A0.6 $52.70 8/31/20231,200 shares $64,722.00 +140.0%N/A2.2 $53.94 8/15/2023500 shares $28,315.00 +66.7%N/A1.3 $56.63 7/31/2023300 shares $16,124.16 +200.0%N/A0.8 $53.75 7/15/2023100 shares $4,825.00 No ChangeN/A0.1 $48.25 6/30/2023100 shares $4,593.72 -66.7%N/A0.2 $45.94 6/15/2023300 shares $14,280.00 No ChangeN/A0.3 $47.60 5/31/2023300 shares $13,287.06 +200.0%N/A0.8 $44.29 5/15/2023100 shares $4,611.80 -98.0%N/A0 $46.12 4/30/20235,000 shares $234,428.00 -2.0%N/A12.5 $46.89 4/15/20235,100 shares $227,893.50 -10.5%N/A8.5 $44.69 3/31/20235,700 shares $236,550.00 -47.2%N/A3.2 $41.50 3/15/202310,800 shares $465,480.00 No ChangeN/A2.8 $43.10 2/15/20232,300 shares $96,715.00 -14.8%N/A1.6 $42.05 1/31/20232,700 shares $114,331.50 +350.0%N/A1.9 $42.35 1/15/2023600 shares $25,806.00 +20.0%N/A0.2 $43.01 12/30/2022500 shares $18,475.00 +400.0%N/A0.2 $36.95 12/15/2022100 shares $3,710.00 -85.7%N/A0 $37.10 11/30/2022700 shares $25,181.80 No ChangeN/A0.2 $35.97 10/31/2022600 shares $16,950.00 -45.5%N/A0.2 $28.25 10/15/20221,100 shares $31,296.10 No ChangeN/A0.2 $28.45 9/30/20221,100 shares $34,100.00 -69.4%N/A0.2 $31.00 9/15/20223,600 shares $105,552.00 +38.5%N/A0.7 $29.32 8/31/20222,600 shares $76,908.00 +2,500.0%N/A0.6 $29.58 8/15/2022100 shares $3,706.00 -66.7%N/A0 $37.06 7/31/2022300 shares $12,447.00 No ChangeN/A0.1 $41.49 6/30/2022100 shares $4,111.00 -90.9%N/A0 $41.11 6/15/20221,100 shares $39,045.60 +1,000.0%N/A0.3 $35.50 5/31/2022100 shares $4,362.00 -50.0%N/A0 $43.62 5/15/2022200 shares $8,361.00 No ChangeN/A0.1 $41.81 4/15/2022100 shares $5,262.00 -50.0%N/A0.1 $52.62Warning: this could blow your mind (Ad)Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here HKMPY Short Interest - Frequently Asked Questions What is Hikma Pharmaceuticals' current short interest? Short interest is the volume of Hikma Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 100 shares of HKMPY short. Learn More on Hikma Pharmaceuticals' current short interest. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Hikma Pharmaceuticals stock? Short selling HKMPY is an investing strategy that aims to generate trading profit from Hikma Pharmaceuticals as its price is falling. HKMPY shares are trading down $1.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hikma Pharmaceuticals? A short squeeze for Hikma Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HKMPY, which in turn drives the price of the stock up even further. How often is Hikma Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HKMPY, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 1933 Industries Short Squeeze 4Cable TV International Short Squeeze 4Front Ventures Short Squeeze AB Science Short Squeeze Acreage Short Squeeze Acreage Short Squeeze Aleafia Health Short Squeeze Almirall Short Squeeze Alvotech Short Squeeze American Green Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HKMPY) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceFed launches fourth dollar overhaulStansberry Research